|
| 37300573 | Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy. | | 2023 |
| 34773794 | Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial. | Leuk Res | 2021 |
| 33637626 | Differential Outcomes in Codon 12/13 and Codon 61 <i>NRAS</i>-Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with <i>NRAS</i>-Mutated Tumors. | Clin Cancer Res | 2021 |
| 33895809 | Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL. | Blood | 2021 |
| 34103329 | Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell Leukemia. | Cancer Discov | 2021 |
| 34407545 | Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib. | Blood | 2021 |
| 34514432 | Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis. | Blood Cancer Discov | 2021 |
| 32997124 | Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial. | JAMA Netw Open | 2020 |
| 31801863 | Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1. | Journal of Virology | 2020 |
| 32276276 | Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. | Blood | 2020 |
| 31515463 | Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation. | Clin Cancer Res | 2019 |
| 30478424 | Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. | Nat Med | 2019 |
| 29066509 | Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805. | Clin Cancer Res | 2018 |
| 28882735 | Integrative factor analysis - An unsupervised method for quantifying cross-study consistency of gene expression data. | Genomics | 2018 |
| 30385433 | Aberrant GSK3β nuclear localization promotes AML growth and drug resistance. | Blood Adv | 2018 |
| 29281174 | Meta-STEPP with random effects. | Research Synthesis Methods | 2018 |
| 28115114 | CD74-ROS1 Fusion in NSCLCÂ Detected by Hybrid Capture-Based Tissue Genomic Profiling and ctDNA Assays. | J Thorac Oncol | 2017 |
| 32913979 | High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers. | JCO Precis Oncol | 2017 |
| 28507205 | A Case of Metastatic Atypical Neuroendocrine Tumor with <i>ALK</i> Translocation and Diffuse Brain Metastases. | Oncologist | 2017 |
| 28376153 | Evidence for a Mesothelial Origin of Body Cavity Effusion Lymphomas. | J Natl Cancer Inst | 2017 |
| 28624448 | Identification of functional hypoxia inducible factor response elements in the human lysyl oxidase gene promoter. | Biochemical and Biophysical Research Communications | 2017 |
| 28881567 | Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide. | Oncotarget | 2017 |
| 28923100 | Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden. | J Immunother Cancer | 2017 |
| 29106415 | Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers. | Nat Genet | 2017 |
| 26662208 | A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908). | Am J Hematol | 2016 |
| 27094489 | Subpopulation Treatment Effect Pattern Plot (STEPP) analysis for continuous, binary, and count outcomes. | Clinical Trials | 2016 |
| 27370606 | New Strategies in Esophageal Carcinoma: Translational Insights from Signaling Pathways and Immune Checkpoints. | Clin Cancer Res | 2016 |
| 27073066 | Meta-STEPP: subpopulation treatment effect pattern plot for individual patient data meta-analysis. | Statistics in Medicine | 2016 |
| 26658701 | Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). | Clin Infect Dis | 2016 |
| 26491160 | Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1. | J Virol | 2015 |
| 25306898 | Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998). | Leukemia | 2015 |
| 25944803 | Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array. | Clin Cancer Res | 2015 |
| 26005638 | Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs. | Meta Gene | 2015 |
| 26218605 | Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses. | PLoS Pathogens | 2015 |
| 26496203 | A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay. | PLoS One | 2015 |
| 24700801 | Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer. | J Natl Cancer Inst | 2014 |
| 25331113 | Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease. | Blood | 2014 |
| 24288121 | E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer. | Cancer Chemotherapy and Pharmacology | 2014 |
| 24986381 | Younger adults with acute myeloid leukemia in remission for â¿¥ 3 years have a high likelihood of cure: The ECOG experience in over 1200 patients. | Leuk Res | 2014 |
| 23550061 | curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome. | Database (Oxford) | 2013 |
| 24174627 | Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. | Blood | 2013 |
| 23444219 | Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study. | Clin Cancer Res | 2013 |
| 22846331 | Estimation of sequencing error rates in short reads. | BMC Bioinformatics | 2012 |
| 21030586 | Liver X receptor (LXR) regulates human adipocyte lipolysis. | J Biol Chem | 2011 |
| 21487108 | High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. | Blood | 2011 |
| 21436879 | Unifying gene expression measures from multiple platforms using factor analysis. | PLoS One | 2011 |
| 20583924 | An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. | Clin Infect Dis | 2010 |
| 20224786 | Characterization of the activation of protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1) by hypoxia inducible factor-2 alpha. | PLoS ONE | 2010 |
| 20129251 | Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. | Cancer Cell | 2010 |
| 19243450 | Amygdala protein kinase C epsilon controls alcohol consumption. | Genes, Brain and Behavior | 2009 |